Recruiting Neuroendocrine Tumors Studies in Indianapolis
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
This study has been designed to determine the safety, tolerability and efficacy of QRX003 lotion 2%, 4% QAM or 4% BID in subjects with Netherton Syndrome (NS) in comparison to vehicle...
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
To assess the safety, tolerability, and efficacy of QRX003 lotion (4%) when added to standard of care treatment regimen, including systemic therapy in subjects with Netherton syndrome...
About Neuroendocrine Tumors Clinical Trials in Indianapolis
Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.
There are currently 2 neuroendocrine tumors clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 50 participants. Research is being sponsored by Quoin Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuroendocrine Tumors Clinical Trials in Indianapolis — FAQ
Are there neuroendocrine tumors clinical trials in Indianapolis?
Yes, there are 2 neuroendocrine tumors clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Indianapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.
Are clinical trials in Indianapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.
What neuroendocrine tumors treatments are being tested?
The 2 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.
Data updated March 2, 2026 from ClinicalTrials.gov